Literature DB >> 19243819

The expression of granulysin in systemic anaplastic large cell lymphoma in childhood.

Noriko Kitamura1, Yohko U Katagiri, Mitsuko Itagaki, Yoshitaka Miyagawa, Keiko Onda, Hajime Okita, Akio Mori, Junichiro Fujimoto, Nobutaka Kiyokawa.   

Abstract

The expression of granulysin, a cytolytic protein produced by activated T and NK cells, has been revealed to be correlated with the prognosis of some adult cancer patients. By examination on various childhood lymphoma tissues, we found that granulysin level was especially high in systemic anaplastic large cell lymphoma (ALCL) cases, whereas no close correlation with the expression of CD96, a marker for activated T and NK cells, was observed. We further demonstrated that both ALCL cells in biopsy specimens and cell lines established from ALCL express granulysin, indicating some correlation of granulysin with biological features of ALCL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243819     DOI: 10.1016/j.leukres.2009.01.032

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Profiles of cytotoxic T lymphocytes in cutaneous lymphoid hyperplasia of the face.

Authors:  Sadanori Furudate; Taku Fujimura; Yumi Kambayashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2013-03-20

2.  Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.

Authors:  Giuseppe Lo Bello; Ayse U Akarca; Maria Raffaella Ambrosio; Claudio Agostinelli; Hernan Molina-Kirsch; Alan Ramsay; Manuel Rodriguez-Justo; Matt Pugh; Shuchun Zhao; Monique DeLisser; Elena Sabattini; Stefan Dojcinov; Stefano A Pileri; Yasodha Natkunam; Lorenzo Leoncini; Teresa Marafioti
Journal:  Virchows Arch       Date:  2018-08-27       Impact factor: 4.064

Review 3.  Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer.

Authors:  Christian Sordo-Bahamonde; Seila Lorenzo-Herrero; Ángel R Payer; Segundo Gonzalez; Alejandro López-Soto
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.